Nexaph peptides, designated neo-exaptation peptides, constitute a intriguing area for therapeutic research. These small entities are engineered with exploit native cellular processes, typically by innovative structural adjustments. The potential lies in their ability with interact with distinct tissue pathways, providing alternative strategies for